Interview with the Editor-in-Chief of Rare Disease and Orphan Drugs Journal--Prof. Daniel Scherman

On November 20, the Editorial Office of Rare Disease and Orphan Drugs Journal interviewed the Editor-in-Chief Prof. Daniel Scherman, who talked about his current research, hotspots and prospects in the field of rare diseases, advice to young scholars and his plans for the future development of the journal. From this video interview, let us take a look at what Prof. Scherman has said.

Q1. We've noticed that you’ve been working on rare diseases for a long time. Can you share with us what motivates you to keep working on this? Also, do you and your team have any latest research progress on it?

Q2. Could you please talk about the impact of gene therapy on rare diseases? What do you think of the current research situation and future development of gene therapy in precision medicine for rare diseases?

Q3. As an outstanding expert in this field, what do you think are the challenges you face now? Is there any advice you would give younger researchers in their careers?

Q4. Could you talk about the current research hotspots and the future prospects in the field of rare diseases?

Q5. As the Editor-in-Chief of Rare Disease and Orphan Drugs Journal, what are your plans and expectations for the future development of the journal?

Respectfully Submitted by the Journal Editorial Office
Rare Disease and Orphan Drugs Journal